| Literature DB >> 21197310 |
Steven Milanese1, Karen Grimmer-Somers.
Abstract
Adolescent low back pain (ALBP) is a common form of adolescent morbidity which remains poorly understood. When attempting a meta-analysis of observational studies into ALBP, in an effort to better understand associated risk factors, it is important that the studies involved are homogenic, particularly in terms of the dependent and independent variables. Our preliminary reading highlighted the potential for lack of homogeneity in descriptors used for ALBP. This review identified 39 studies of ALBP prevalence which fulfilled the inclusion criteria, ie, English language, involving adolescents (aged 10 to 19 years), pain localized to lumbar region, and not involving specific subgroups such as athletes and dancers. Descriptions for ALBP used in the literature were categorized into three categories: general ALBP, chronic/recurrent ALBP, and severe/disabling ALBP. Whilst the comparison of period prevalence rates for each category suggest that the three represent different forms of ALBP, it remains unclear whether they represented different stages on a continuum, or represent separate entities. The optimal period prevalence for ALBP recollection depends on the category of ALBP. For general ALBP the optimal period prevalence appears to be up to 12 months, with average lifetime prevalence rates similar to 1-year prevalence rates, suggesting an influence of memory decay on pain recall.Entities:
Keywords: adolescent; lumbar pain; teenager
Year: 2010 PMID: 21197310 PMCID: PMC3004638 DOI: 10.2147/jpr.s10025
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Potential causes for ALBP
Mechanical
Disc lesions or herniations Spondylolysis and spondylolisthesis Scheuermanns disease Overuse injuries Traumatic injuries Congenital disorders – scoliosis, spinal fusion, spinalstenosis Inflammatory/Infectious
Diskitis Disc calcifications Inflammatory rheumatic disorders Infections of the bone/soft tissue Arachnoiditis Neoplasms
Benign tumors – osteoid osteoma, osteochondroma, lipoma, giant cell tumor, Malignant tumors – Ewings sarcoma, osteogenic sarcoma, neuroblastoma, cord tumors Radiation Therapy sequalae Hematolgic disorders – sickle cell, leukemia, Hodgkin’s, and non-Hodgkin’s lymphoma Aortic dissection Intra-abdominal diseases Fibrositis Marfans disease Psychological |
Notes: Adapted from Balague and Nordin, and King.18
Characteristics of the studies presenting ALBP prevalence data used in this review
| Origin of study sample | European | 34 | 77 | 267,976 | 96.3 |
| Middle East | 2 | 4.6 | 5,400 | 1.9 | |
| Australasia | 3 | 6.8 | 2,124 | 0.8 | |
| Americas | 3 | 6.8 | 1,879 | 0.7 | |
| Africa | 2 | 4.6 | 826 | 0.3 | |
| Data collection methodology | School | 40 | 91 | 60,083 | 21.6 |
| National Survey | 4 | 9 | 218,122 | 78.4 | |
| Period recall (% add up to greater than 100 as some studies use multiple recall periods) | PP | 14 | 31.8 | 21,737 | 7.8 |
| 1M | 15 | 34.1 | 15,503 | 5.6 | |
| 3M | 3 | 6.8 | 4,871 | 1.8 | |
| 6M | 6 | 13.6 | 206,988 | 74.4 | |
| 1Y | 12 | 27.3 | 36,935 | 13.3 | |
| LT | 20 | 45.5 | 38,247 | 13.7 | |
Abbreviations: ALBP, adolescent low back pain; PP, point prevalence; 1W, 1-week; 1M, 1-month; 3M, 3-month; 6M, 6-month; 1Y, 1-year; LT, lifetime.
Figure 1Number of studies on adolescent low back pain prevalence published by decade.
Characteristics of the studies presenting ALBP prevalence data used in this review
| Grimmer and Williams, | Any pain in the low back. | General |
| Watson et al, | Low back pain lasting for one day or longer. | General |
| Auvinen et al | Any pain or aching in the low back area. | General |
| Olsen et al | Pain or other trouble with the lower part of the back. | General |
| Sjolie | Pain, ache, or discomfort in the lower back, not related to trauma or menstrual pain. | General |
| Ebrall, | Any pain or discomfort in the low back. | General |
| Mierau et al | Pain, soreness, or hurt over the low back. | General |
| Kristensen et al | Any ache, pain, or discomfort in the lower back. | General |
| Jones et al | Any low back pain or pain occurring regularly. | General, Chronic/recurrent |
| Vikat et al | Pain in the low back at least weekly. | Chronic/recurrent |
| El-Metwally et al, | Any pain or ache in the low back – paper reported on monthly or weekly recurrence only. | Chronic/recurrent |
| Feldman et al | Low back pain with a frequency of at least once per week. | Chronic/recurrent |
| Hakala et al | Back pain at least weekly over the past half a year. | Chronic/recurrent |
| Diepenmaat et al | Pain lasting a day or longer with >4 days per month. | Chronic/recurrent |
| Taimela et al, | Low back pain that interfered with school, work, or leisure activities. | Severe/disabling |
| Masiero et al | Any nonoccasional pain that in some way limited the student in daily activities. | Severe/disabling |
| Burton et al | Quite bad pain, other than occasional twinges. | Severe/disabling |
| Prendeville and Dockrell | An episode of low back pain and/or discomfort that interrupted normal daily activities and/or required treatment. Low back pain due to any structural abnormalities or menstrual pain is excluded. | Severe/disabling |
Period prevalence rates for each category of ALBP
| Auvinen et al | 39 | ||||||
| Balague et al | 13 | 40 | |||||
| Balague et al | 9.4 | 32.5 | |||||
| Balague et al | 20 | ||||||
| Balague et al | 51 | ||||||
| Bejia et al | 13 | 28.4 | |||||
| Cakmak et al | 32 | ||||||
| Ebrall | 16.7 | 57 | |||||
| Grimmer and Williams | 25.4 | ||||||
| Harreby et al | 13.9 | 30.6 | 50.8 | 58.9 | |||
| Jones et al | 18.6 | ||||||
| Jones et al | 15.5 | 40.2 | |||||
| Jones et al | 25.4 | ||||||
| Kjaer et al | 22 | ||||||
| Kovacs et al | 25 | 61 | |||||
| Kristensen et al | 63 | ||||||
| Legg et al | 48 | ||||||
| Mierau et al | 33 | ||||||
| Mogensen et al | 40 | ||||||
| Mohseni-Bandpei et al | 15 | 14 | 15.6 | 17.4 | |||
| Murphy et al | 20 | 36 | |||||
| Murphy et al | 22 | 55 | |||||
| Olsen et al | 22 | 30.4 | |||||
| Prista et al | 58 | ||||||
| Shehab et al | 35 | 57.8 | |||||
| Sjolie | 57 | ||||||
| Skoffer and Foldspang | 51.3 | 60.3 | 64.8 | ||||
| Staes et al | 38 | ||||||
| Troussier et al | 23 | ||||||
| Van Gent et al | 46.5 | ||||||
| Watson et al | 23.9 | ||||||
| Wedderkopp et al | 14.8 | ||||||
| Diepenmaat et al | 7.5 | ||||||
| El-Metwally et al | 22.4 | ||||||
| Feldman et al | 24.9 | ||||||
| Balague et al | 48 | ||||||
| Jones et al | 13.1 | ||||||
| Prista et al | 12 | 13.5 | 28 | ||||
| Shehab et al | 36 | ||||||
| Staes et al | 3 | ||||||
| Sjolie | 32 | ||||||
| Vikat et al | 27 | ||||||
| Hakala et al | 11.7 | ||||||
| Kristensen et al | 22 | ||||||
| Skoffer and Foldspang | 24.2 | ||||||
| Kujala et al | 10.7 | ||||||
| Masiero et al | 20.5 | ||||||
| Prendeville and Dockrell | 17 | 28 | 41.5 | ||||
| Taimela et al | 14.2 | ||||||
| Kjaer et al | 8 | ||||||
| Balague et al | 24.3 | ||||||
| Burton et al | 7 | 30 | |||||
Abbreviations: ALBP, adolescent low back pain; PP, point prevalence; 1W, 1-week; 1M, 1-month; 3M, 3-month; 6M, 6-month; 1Y, 1-year; LT, lifetime
Summary of period prevalence rates for each category of adolescent low back pain
| 0–1 week | Average (50th %ile) | 16.1 | 12 | N/A |
| Range (%min–%max) | 9.4–35 | 7–17 | N/A | |
| No of Studies | 12 | 2 | N/A | |
| 1-month | Average (50th %ile) | 24.65 | 16.15 | 7.5 |
| Range (%min–%max) | 14–46.5 | 8–24.3 | 3–12 | |
| No of Studies | 12 | 2 | 3 | |
| 3-month | Average (50th %ile) | 51.3 | 24.2 | 22.4 |
| Range (%min–%max) | 51.3 | 24.2 | 22.4 | |
| No of Studies | 1 | 1 | 1 | |
| 6-month | Average (50th %ile) | 33 | N/A | 24.9 |
| Range (%min–%max) | 15.6–39 | N/A | 11.7–27 | |
| No of Studies | 3 | N/A | 3 | |
| 12-month | Average (50th %ile) | 50.8 | 20.5 | 13.5 |
| Range (%min–%max) | 17.4–60.3 | 10.7–28 | 13.1–32 | |
| No of Studies | 5 | 5 | 3 | |
| Lifetime | Average (50th %ile) | 51 | 35.75 | 36 |
| Range (%min–%max) | 20–64.8 | 30–41.5 | 28–48 | |
| No of Studies | 17 | 2 | 3 | |